Diaceutics (LON:DXRX) Trading 0.7% Higher – Here’s Why

Diaceutics PLC (LON:DXRX)’s share price traded up 0.7% during trading on Wednesday . The company traded as high as GBX 143 and last traded at GBX 143. Approximately 67,088 shares changed hands during trading, a decline of 68% from the average daily volume of 211,010 shares. The stock had previously closed at GBX 142.

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group reissued a “buy” rating and issued a GBX 215 target price on shares of Diaceutics in a research report on Wednesday, July 29th. Two investment analysts have rated the stock with a Buy rating, According to MarketBeat, the stock currently has an average rating of “Buy” and an average target price of GBX 215.

Diaceutics Trading Up 0.7%

The company has a quick ratio of 9.92, a current ratio of 3.43 and a debt-to-equity ratio of 2.85. The firm has a market capitalization of £116.70 million, a PE ratio of 1,253.64 and a beta of 0.89. The stock’s fifty day simple moving average is GBX 141.64 and its 200 day simple moving average is GBX 151.85.

Diaceutics (LON:DXRX) last issued its quarterly earnings results on Tuesday, May 26th. The company reported GBX 11 earnings per share for the quarter. Diaceutics had a net margin of 0.25% and a return on equity of 0.25%. The business had revenue of GBX 3,844 million for the quarter. On average, sell-side analysts predict that Diaceutics PLC will post 1.0107919 earnings per share for the current year.

About Diaceutics

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world’s leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX – The Diagnostics Network®.